703-1100

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
703 (USA) · Dr. Okafor
consented 2013-03-13

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-05 (study day 24.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-05 (study day 24.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-04-05 (study day 24.0); relationship: PROBABLE

moderate assessed

Moderate CATARACT OPERATION — outcome: RECOVERED/RESOLVED; onset 2013-04-25 (study day 44.0); relationship: NONE

moderate assessed

Moderate OEDEMA PERIPHERAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-28 (study day -13.0); relationship: REMOTE

moderate assessed

Moderate OEDEMA PERIPHERAL — outcome: RECOVERED/RESOLVED; onset 2013-02-28 (study day -13.0); relationship: REMOTE

mild assessed

Mild OEDEMA PERIPHERAL — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-07-17 (study day 127.0); relationship: REMOTE

mild assessed

Mild OEDEMA PERIPHERAL — outcome: RECOVERED/RESOLVED; onset 2013-07-17 (study day 127.0); relationship: REMOTE

moderate assessed

Moderate UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-05-27 (study day 76.0); relationship: REMOTE

Data queries

No data queries.